| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +497K | 91.5% | $0.65 | +$324K |
| Sells | 5 | -46K | 8.5% | $1.17 | -$53.6K |
| Net | -2 | +451K | 83.1% | +$271K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Faheem Hasnain | President & CEO, Director | $3.72M | +$224K | +6.39% | Jun 21, 2024 |
| Waage Christian | EVP, Tech Ops and Admin | $756K | -$7.43K | -0.97% | Mar 27, 2024 |
| Bryan Giraudo | Coo/Cfo | $284K | +$51.7K | +22.3% | Jun 18, 2024 |
| Richard Aranda | Chief Medical Officer | $132K | -$6.6K | -4.77% | Jun 24, 2024 |
| Caryn Peterson | EVP, Regulatory Affairs | $66.3K | -$5.34K | -7.46% | Mar 18, 2024 |
| Laura Carter | Chief Scientific Officer | $60.1K | Mar 20, 2023 | ||
| Sandra Milligan | Director | $25.2K | Jun 6, 2024 | ||
| Robert Paul Smith JR | Chief Commercial Officer | $15.1K | +$15.1K | Jun 17, 2024 | |
| Joshua H. Bilenker | Director | Jun 9, 2022 | |||
| Steven D. Nathan | Director | Mar 11, 2024 | |||
| Renee D. Gala | Director | Jun 8, 2023 | |||
| Thomas O. Daniel | Director | Jun 6, 2024 | |||
| John D. Quisel | Director | Jun 6, 2024 | |||
| Kristina Burow | Director | Jun 8, 2023 | |||
| Russell J. Cox | Director | Jun 6, 2024 | |||
| Skye Drynan | Director | Mar 11, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|